Diabetes

As hundreds of thousands of diabetics get health coverage under the federal law, insurance companies are aggressively targeting this glut of new patients, who are expensive to treat and often lax in taking medications and following their diet.

The American Journal of Managed Care brought together than 125 diabetes advocates, providers, and educators, along with health plan leaders and pharmaceutical executives, to Princeton, N.J. Attendees gained insights into giving persons with diabetes with the right level of support to manage their disease.

Amy Tenderich of DiabetesMine.com, a web-based news source for persons with diabetes, took part in panel discussions at Patient-Centered Diabetes Care: Putting Theory into Practice, sponsored by The American Journal of Managed Care.

As the healthcare landscape evolves, so will the way that providers help patients manage their diabetes.

Fighting the nation's related epidemics of obesity and type 2 diabetes mellitus will take a nationwide strategy that increasingly tailors treatment to individual patient needs, and new approaches are need to get patients to take medications and make lifestyle changes to be healthier. That was the consensus of an expert panel convened Thursday by The American Journal of Managed Care to open its two-day conference, Patient-Centered Diabetes Care: Putting Theory into Practice, which is taking place at the Princeton Marriott at Forrestal. The conference continues today, opening with a keynote address by Robert A. Gabbay, MD, chief medical officer at the Joslin Diabetes Center, Harvard Medical School.

Ironman triathlete Jay Hewitt will speak tomorrow at the evening reception of Patient-Centered Diabetes Care: Putting Theory into Practice, which is bringing leaders in diabetes healthcare delivery to the Princeton Marriott at Forrestal. On Friday, Dr. Robert Gabbay, chief medical officer of the Joslin Diabetes Center, will offer a keynote address.

Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president, Joslin Diabetes Center, says that there are opportunities for treating diabetes within accountable care organizations (ACOs).

Metformin, the go-to drug for patients diagnosed with type 2 diabetes mellitus (T2DM), may help control glycated hemoglobin (A1C) levels, but it does not help prevent heart failure in heart attack patients who do not have the disease, according to a new study from the Netherlands.

Bariatric surgery has more powerful long-term effects on controlling type 2 diabetes mellitus (T2DM) that medical therapy alone, according to the largest, long-term study comparing methods.

Should patients with moderately elevated levels of triglycerides be treated, even while cardiologists await the results of a trial that may provide a definitive answer?

From a session called How to Navigate the Maze of Pharmacotherapy in Diabetes? to oral abstracts and posters, the relationship between cardiac risks and rising incidence of type 2 diabetes mellitus received plenty of attention Saturday at the 63rd Scientific Sessions of the American College of Cardiology, being held in Washington, DC.

Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center, highlights why stakeholders should attend the Patient-Centered Diabetes Care: Putting Theory into Practice event on April 10-11, in Princeton, NJ.

Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.

Accountable care organizations (ACOs) and other population health initiatives cannot succeed without health information being able to flow between healthcare organizations and providers.

Will Share Personal Account of Managing Condition at AJMC Event: Patient-Centered Diabetes Care: Putting Theory into Practice

'In order to get technology to truly work for physicians, it must drive productivity'

Decreased out-of-pocket spending on prescription drugs accounts for reduced financial burden of care to patients, and is consistent with improved access to care.

New research offers high-quality, empirical data on the V-BID plan features that appear most effective for stimulating greater medication adherence.

Can a diabetic's likelihood of developing complications depend on picking the right doctor? A study suggests it can.

Joslin's Dr. Robert Gabbay, USC's Dr. Geoffrey Joyce, and UnitedHealthcare's Dr. Deneen Vojta are among the lineup of national speakers coming to the Princeton Marriott at Forrestal April 10-11.